App-Quantinova.ai

The TRIFLOW study; A randomised, cross-over study evaluating the effects of inhaled beclometasone/formoterol/glycopyrronium (BDP/F/G on hyperinflation in COPD

Dave Singh - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Seebri Breezhaler

COPD exacerbation rates by month in the ETHOS trial with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI at two ICS dose levels

Fernando J. Martinez - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

budesonide + formoterol fuma

Effect of triple therapy with extra-fine BDP/FF/GB pMDI vs non-triple maintenance therapies on severe COPD exacerbations. A pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies

Dave Singh - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Seebri Breezhaler

Lung deposition of two bronchodilators in subjects with (COPD when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI

Glenn Crater - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Revefenacin

Inhaled bacterial mimetic increases PAD4-dependent NETosis in the lungs

Theresa Andreasson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Hypertension in chronic obstructive pulmonary disease (COPD: A review of current practice

Richard Cooper - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR

Maria Mikus - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

N/A

Anti-IL-5 therapy and the airway microbiome in asthma

Ashley Sullivan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial

Elisabeth H.D. Bel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Mepolizumab

Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function

Jorge F. Maspero - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dupilumab

The impact of anti-IgE treatment on the airway microbiome in asthma

Ashley Sullivan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Omalizumab

Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE

Michael E. Wechsler - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dupilumab

Airway sensory nerve sensitivity in adolescents with eosinophilic and non-eosinophilic asthma

Hajar Ali - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Oxidative stress and mitochondrial dysfunction in a novel in vivo exacerbation model of severe asthma

Jack Lowe - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Exercise moderates inflammation in asthma through increased redox buffering capacity

Anna Freeman - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Inhibition of Mast Cell Degranulation by Surfactant Protein D

Mohammad Leily - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital disorder of glycosylation 2C

N/A

Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC

Philip Mitchelmore - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Late Breaking Abstract - The Role of the chemokine receptor CCR3 in House Dust Mite (HDM induced experimental asthma

Susanne Krammer - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

BMI is reduced in COPD

Xin Yao - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis

Asif Khan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Filters

45280 Abstracts